P2Y12 inhibitor–based antiplatelet therapy versus aspirin therapy after coronary artery bypass grafting: Systematic review and meta-analysis
JTCVS Open · 2026-10 · 102187
DOI: 10.1016/j.xjon.2026.102187 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift JTCVS Open, 2026-10. Verfasst von Ali Saad Al-Shammari und 8 weiteren Autor:innen. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Al-Shammari, A. S., Kayani, A. M. A., Giamundo, D. M., Patel, N., Shahzaib, M., Lefranc, W., Hageen, A. W., AlTaii, H., & Abdulameer, H. (2026). P2Y12 inhibitor–based antiplatelet therapy versus aspirin therapy after coronary artery bypass grafting: Systematic review and meta-analysis. JTCVS Open, 102187. https://doi.org/10.1016/j.xjon.2026.102187
Vancouver
Al-Shammari AS, Kayani AMA, Giamundo DM, Patel N, Shahzaib M, Lefranc W, et al. P2Y12 inhibitor–based antiplatelet therapy versus aspirin therapy after coronary artery bypass grafting: Systematic review and meta-analysis. JTCVS Open. 2026:102187. doi:10.1016/j.xjon.2026.102187
BibTeX
@article{AlShammari2026,
author = {Al-Shammari, Ali Saad and Kayani, Abdul Mueez Alam and Giamundo, Domenico Mario and Patel, Nixat and Shahzaib, Muhammad and Lefranc, Wodwentzky and Hageen, Ahmed W. and AlTaii, Haider and Abdulameer, Halah},
title = {P2Y12 inhibitor–based antiplatelet therapy versus aspirin therapy after coronary artery bypass grafting: Systematic review and meta-analysis},
journal = {JTCVS Open},
year = {2026},
pages = {102187},
doi = {10.1016/j.xjon.2026.102187}
}
EUVIMED